Cheshire Cardiology Limited 09126851 false 2022-10-01 2023-03-31 2023-03-31 The principal activity of the company is veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true 09126851 2022-10-01 2023-03-31 09126851 2023-03-31 09126851 core:RetainedEarningsAccumulatedLosses 2023-03-31 09126851 core:ShareCapital 2023-03-31 09126851 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 09126851 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 09126851 bus:SmallEntities 2022-10-01 2023-03-31 09126851 bus:AuditExemptWithAccountantsReport 2022-10-01 2023-03-31 09126851 bus:FullAccounts 2022-10-01 2023-03-31 09126851 bus:SmallCompaniesRegimeForAccounts 2022-10-01 2023-03-31 09126851 bus:RegisteredOffice 2022-10-01 2023-03-31 09126851 bus:Director1 2022-10-01 2023-03-31 09126851 bus:PrivateLimitedCompanyLtd 2022-10-01 2023-03-31 09126851 core:MotorVehicles 2022-10-01 2023-03-31 09126851 core:PlantMachinery 2022-10-01 2023-03-31 09126851 1 2022-10-01 2023-03-31 09126851 countries:AllCountries 2022-10-01 2023-03-31 09126851 2022-09-30 09126851 2021-10-01 2022-09-30 09126851 2022-09-30 09126851 core:RetainedEarningsAccumulatedLosses 2022-09-30 09126851 core:ShareCapital 2022-09-30 09126851 core:CurrentFinancialInstruments core:WithinOneYear 2022-09-30 09126851 core:Non-currentFinancialInstruments core:AfterOneYear 2022-09-30 iso4217:GBP xbrli:pure

Registration number: 09126851

Cheshire Cardiology Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Period from 1 October 2022 to 31 March 2023

 

Cheshire Cardiology Limited

Contents

Abridged Balance Sheet

1 to 2

Notes to the Unaudited Abridged Financial Statements

3 to 4

 

Cheshire Cardiology Limited

(Registration number: 09126851)
Abridged Balance Sheet as at 31 March 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

910,458

342,772

Current assets

 

Debtors

39,948

37,395

Cash at bank and in hand

 

33,855

319,109

 

73,803

356,504

Creditors: Amounts falling due within one year

(344,266)

(272,116)

Net current (liabilities)/assets

 

(270,463)

84,388

Total assets less current liabilities

 

639,995

427,160

Creditors: Amounts falling due after more than one year

(354,477)

(214,549)

Provisions for liabilities

(55,210)

(13,455)

Net assets

 

230,308

199,156

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

230,208

199,056

Total equity

 

230,308

199,156

 

Cheshire Cardiology Limited

(Registration number: 09126851)
Abridged Balance Sheet as at 31 March 2023

For the financial period ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 25 September 2023
 

Ms E Dutton

Director

 

Cheshire Cardiology Limited

Notes to the Unaudited Abridged Financial Statements for the Period from 1 October 2022 to 31 March 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
The School House
Chester Road
Northwich
Cheshire
CW8 1LE
England

These financial statements were authorised for issue by the director on 25 September 2023.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Disclosure of long or short period

The accounts have been prepared for the 6 month period to 31 March 2023 to coincide with the director's personal affairs.

Going concern

The financial statements have been prepared on a going concern basis. Of the company's current liabilities an amount is owed to the director. The director has agreed to not demand repayment of an amount so as to not jeopardise the future of the company.

Revenue recognition

Turnover represents the amounts, excluding value added tax, derived from the provision of goods and services to customers during the year.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

 

Cheshire Cardiology Limited

Notes to the Unaudited Abridged Financial Statements for the Period from 1 October 2022 to 31 March 2023

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Motor vehicles

25% reducing balance

Plant and machinery

20% reducing balance

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 5 (2022 - 5).

4

Tangible assets

Total
£

Cost or valuation

At 1 October 2022

439,533

Additions

593,164

At 31 March 2023

1,032,697

Depreciation

At 1 October 2022

96,762

Charge for the period

25,477

At 31 March 2023

122,239

Carrying amount

At 31 March 2023

910,458

At 30 September 2022

342,772

Included within the net book value of land and buildings above is £685,478 (2022 - £287,946) in respect of freehold land and buildings.
 

5

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £265,000 (2022 - £128,024).